Beyond the Breaking News

Monkeypox is not 'only circulating in countries distributing Pfizer-BioNTech vaccine'

United States News News

Monkeypox is not 'only circulating in countries distributing Pfizer-BioNTech vaccine'
United States Latest News,United States Headlines

🌎 Posts shared on Facebook and Twitter claim monkeypox is 'only circulating in countries distributing the Pfizer-BioNTech vaccine'. This is false ❌ There is no link between monkeypox and the vaccine, experts say

But medical experts told AFP the claim that monkeypox outbreaks are linked to Pfizer-BioNTech's Covid vaccine is false., although monkeypox is not highly contagious, it can be"transmitted from one person to another by close contact with lesions, body fluids, respiratory droplets and contaminated materials such as bedding.

" Jaya Dantas, professor of international health at Australia's Curtin University, said she had found no correlation between recent monkeypox outbreaks and the countries where the Pfizer-BioNTech vaccine has been administered. "The Pfizer vaccine has been administered in 180 countries and most of these do not have any cases of monkeypox," Dantas told AFP. Peter Collignon, a professor from the Australian National University Medical School, told AFP that monkeypox existed for decades before Covid-19 vaccines were created. "Monkeypox has been known for decades, long before Covid-19 vaccines have been developed," Collignon said. He went on to say that some mRNA vaccines -- such as the one developed by Pfizer-BioNTech -- have"side effects but serious ones are relatively uncommon". The claim that the WHO has not received reports of monkeypox cases from countries not using the Pfizer-BioNTech vaccine is also false.-- have reported at least one case of monkeypox as of August 9 but their respective health authorities do not administer Pfizer-BioNTech's vaccine to the public. A Pfizer spokesperson told AFP that governments and experts around the world have continually reviewed the vaccine's data to ensure it is safe."The safety profile for the vaccine for all authorised groups continues to be favourable," the spokesperson said.The WHO also told AFP that the map that purports to show the spread of monkeypox around the world had been altered. "The red writing and circle have been added. Also, the heading in bold is not ours," a WHO spokesperson said.published on June 27, 2022.The spokesperson went on to say the claim that"health authorities are scrambling to cover up the damage of injecting millions of people with an experimental mRNA injection" is false. The other map in the false posts that purports to show the distribution of the Pfizer-BioNTech vaccine is outdated.in the Postgraduate Medical Journal first published in August 2021 showing the distribution of Pfizer vaccines as of May 16, 2021Collignon said mutations and increasing levels of international travel after the lifting of Covid-related restrictions have contributed to recent outbreaks outside of Africa.The WHO wrote in its latest update inthat the wide geographic spread of cases indicates that the monkeypox virus"might have been circulating below levels detectable by the surveillance systems and sustained human-to-human transmission might have been undetected for a period of time". AFP has previously debunked claims of adverse effects caused by the Covid vaccine; including that the vaccine is

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

AFPFactCheck /  🏆 540. in US

 

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer Agrees to $5.4 Billion Deal for Global Blood TherapeuticsPfizer Agrees to $5.4 Billion Deal for Global Blood TherapeuticsPfizer has agreed to buy Global Blood Therapeutics for $5.4 billion, a deal that will give the big drugmaker a foothold in the treatment of sickle-cell disease.
Read more »

Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4 bln dealFlush with cash, Pfizer buys Global Blood Therapeutics in $5.4 bln dealPfizer Inc on Monday agreed to pay $5.4 billion in cash for sickle cell disease drugmaker Global Blood Therapeutics , as it looks to capitalize on a surge in revenue from its COVID-19 vaccine and treatment.
Read more »

Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce TrialsVaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce TrialsPfizer and BioNTech will begin trials of their updated mRNA Covid-19 vaccine designed to protect against the newer BA.4 and BA.5 sub-variants of the coronavirus later this month.
Read more »

Pfizer to buy South SF-based Global Blood Therapeutics in $5.4B dealPfizer to buy South SF-based Global Blood Therapeutics in $5.4B dealPfizer will spend about $5.4 billion to buy Global Blood Therapeutics as the pharmaceutical giant continues to invest some of the cash influx reaped during the COVID-19 pandemic.
Read more »

Pfizer just started a late-stage clinical trial of a Lyme disease vaccinePfizer just started a late-stage clinical trial of a Lyme disease vaccineIf the trial succeeds, the vaccine could be the first human immunization for Lyme disease in the U.S. in two decades.
Read more »

Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce TrialsVaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce TrialsPfizer and BioNTech will begin trials of their updated mRNA Covid-19 vaccine designed to protect against the newer BA.4 and BA.5 sub-variants of the coronavirus later this month.
Read more »



Render Time: 2026-06-12 23:42:08